USE OF A H4 AGONIST MOLECULE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
US2015148538A1
Use of an h4 agonist molecule to treat acute leukemia
FR3013595A1
Use of h4 agonist molecule for the treatment of acute leukemia
US2013303565A1
Use of a new histamine h4 agonist for the treatment of acute leukemia
FR2990859A1
Use of an agonist h4 molecule for the treatment of mucoviscidosis
FR2898496A1
Use of pharmaceutical composition having enantiomer of tritoqualine and proton pump inhibitor to treat digestive inflammatory conditions e.g. gastric ulcer, gastritis, duodenitis, dyspepsia, oesophagitis and gastro-oesophageal reflux
FR2896156A1
Composition, useful for the preparation of drug to treat inflammatory phenomena and hyper secretion of gastric juices such as gastritis and gastric ulcer, comprises levogyre or dextrogyre enantiomers of e.g. tritoqualine
FR2883477A1
Novel use of tritoqualine for the treatment of inflamatory diseases digestive and more particularly gastric and esophageal
